Y-mAbs Therapeutics, Inc. Restructuring Charges
Y-mAbs Therapeutics, Inc. reported Restructuring Charges of $4.48 million for the 12-month period ending 2023-12-31, per its 10-K filed 2024-02-29.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:RestructuringCharges · last filed 2024-11-08
- Y-mAbs Therapeutics, Inc. restructuring charges for the quarter ending 2023-12-31 was $0.00.
- Y-mAbs Therapeutics, Inc. restructuring charges for the quarter ending 2023-09-30 was $0.00.
- Y-mAbs Therapeutics, Inc. restructuring charges for the quarter ending 2023-06-30 was $0.00.
- Y-mAbs Therapeutics, Inc. restructuring charges for the quarter ending 2023-03-31 was $4.48M.
- Y-mAbs Therapeutics, Inc. restructuring charges for fiscal 2023 was $4.48M.
| Period end | Restructuring Charges 3 month | Restructuring Charges 6 month | Restructuring Charges 9 month | Restructuring Charges 12 month |
|---|---|---|---|---|
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $0.00 derived: sum of 2 quarters · filed 2024-11-08 | $0.00 derived: sum of 3 quarters · filed 2024-11-08 | $4.48M 10-K · filed 2024-02-29 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | $0.00 derived: sum of 2 quarters · filed 2024-11-08 | $4.48M 10-Q · filed 2024-11-08 | |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12 | $4.48M 10-Q · filed 2024-08-12 | ||
| 2023-03-31 | $4.48M 10-Q · filed 2024-05-07 |